Further Information
IL18, interleukin 18 (interferon-gamma-inducing factor), IGIF, IL-18, IL-1g, IL1F4, MGC12320, IL-1 gamma, interferon-gamma-inducing factor, interleukin 18, interleukin-1 gamma, interleukin-18
Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot:Approx 23kDa band observed in lysates of cell line HeLa (calculated MW of 22.3kDa according to NP_001553.1). Recommended concentration: 1-3ug/ml. Primary incubation was 1 hour.
- An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA, Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. The Journal of infectious diseases 2008 Oct 198 (8): 1159-65.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-NPPDNIKDTKSDI
3606
interleukin 18 (interferon-gamma-inducing factor)
IL18
Homo sapiens
Liquid
NP_001553.1, NP_001230140.1
4504653
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer ,Chemokines & Cytokines,Innate Immunity
This antibody is expected to recognise both reported isoforms (NP_001553.1; NP_001230140.1).
Q14116